The French pharmaceutical company Sanofi reported positive results from a trial of its COVID-19 vaccine on Monday, which has been hit by several months of delays. Developed with Britain’s GlaxoSmithKline, the interim phase 2 results showed the jab “induced the production of high concentrations of neutralizing antibodies in adults of all ages, at levels comparable to those observed in people who had recovered from a COVID infection," the laboratory said ...